Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Lidocaine prilocaine

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   44339   clinical trials with a EudraCT protocol, of which   7369   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    20 result(s) found for: Lidocaine prilocaine. Displaying page 1 of 1.
    EudraCT Number: 2012-004993-25 Sponsor Protocol Number: LIDPR25VER Start Date*: 2013-01-10
    Sponsor Name:Verisfield (UK) Ltd
    Full Title: A multicenter, randomized, patient-blind, investigator-blind, placebo-controlled, crossover study of Lidocaine + Prilocaine/Verisfield (2.5+2.5)% w/w cream and EMLA/AstraZeneca cream, in patients u...
    Medical condition: Pain related to the cannulation of arteriovenous fistula cannulation in haemodialysis patients.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GR (Completed)
    Trial results: View results
    EudraCT Number: 2015-005334-22 Sponsor Protocol Number: 347PUNCIOHEMODIALISIS Start Date*: 2016-05-31
    Sponsor Name:HOSPITAL DE PALAMÓS
    Full Title: CLINICAL TRIAL FOR THE TREATMENT OF PAIN IN HEMODIALYSIS PUNCTURE WITH LIDOCAINE / PRILOCAINE, VERSUS CHLOROETHYL, CROSSOVER RANDOMIZED STUDY
    Medical condition: Hemodialysis is the most commonly used therapy for renal replacement being the arteriovenous fistula used for vascular access . Venipuncture in patients causes stress, pain and anxiety.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-005006-31 Sponsor Protocol Number: EML053774_002 Start Date*: 2007-04-03
    Sponsor Name:Merck Sante France
    Full Title: A randomized, stratified on age, parallel group design study to investigate the safety, tolerability and pharmacokinetics after a 60 minutes application of 4% lidocaine cream compared to EMLA® crea...
    Medical condition: Topical anesthesia of healthy skin before venous or subcutaneous puncture, before superficial cutaneous instrumental surgery or laser beam (tattoo or cutaneousangioma)
    Disease:
    Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: FR (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2014-003610-86 Sponsor Protocol Number: EMCD1403 Start Date*: 2014-11-14
    Sponsor Name:
    Full Title: A double blind randomized controlled trial comparing the efficacy of 7% lidocaine / 7% tetracaine cream versus 2,5% lidocaine / 2,5% prilocaine cream for local anaesthesia during laser treatment of...
    Medical condition: Pain during laser treatment of: 1. Tattoo 2. Acne keloidalis nuchae
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-003650-15 Sponsor Protocol Number: PSD502-PE-005 Start Date*: 2008-12-29
    Sponsor Name:Plethora Solutions Ltd
    Full Title: A Phase II, multi-centre, double-blind, randomised, placebo-controlled, 4-way cross-over, dose-range finding study to evaluate efficacy and safety and tolerability of PSD502 in subjects with premat...
    Medical condition: Premature Ejaculation
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036596 Premature ejaculation PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-002264-25 Sponsor Protocol Number: Start Date*: 2011-10-12
    Sponsor Name:Medizinische Universität Wien,Univ.Klinik f.Anästhesie,Allgemeine Intensivmedizin u.Schmerztherapie
    Full Title: Cooling for reducing treatment-related pain when applying capsaicin 8% patch
    Medical condition: healthy volunteers
    Disease:
    Population Age: Gender: Male, Female
    Trial protocol: AT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2011-000750-37 Sponsor Protocol Number: 35711 Start Date*: 2011-03-29
    Sponsor Name:Isala Klinieken
    Full Title: A randomised clinical trial on the effectiveness of Emla and Rapydan for prevention of vena punction-induced pain in children.
    Medical condition: Venipuncture, especially in children, is associated with pain and discomfort. For this reason, often use a local anesthetic.
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-004652-13 Sponsor Protocol Number: PSD502-PM-001 Start Date*: 2006-02-01
    Sponsor Name:PLETHORA SOLUTIONS LIMITED
    Full Title: Phase II, multi centre, randomised, double blind, placebo controlled, pilot study to determine efficacy, safety, tolerability and preliminary pharmacokinetics of PSD502 in the management of pain fr...
    Medical condition: management of pain from donor sites in burns subjects undergoing skin grafts
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2010-019715-38 Sponsor Protocol Number: Cries-2010 Start Date*: 2010-07-30
    Sponsor Name:Universitätsmedizin der Johannes Gutenberg-Universität Mainz
    Full Title: Placebokontrollierte, prospektive Beobachtung des Schmerzempfindens bei Probanden während der mechanischen Epilation mit dem Braun Expressive Epilationsgerät nach Auftragen von Lokaltherapeutika (E...
    Medical condition: Algesia in healthy subjects during mechanical epilation
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-001816-20 Sponsor Protocol Number: 1.1000 Start Date*: 2014-08-28
    Sponsor Name:Academic Medical Center, Amsterdam
    Full Title: Fractional CO2 laser assisted delivery of topical anesthetics: a randomized controlled pilot study
    Medical condition: local anesthesia of the skin prior to minor cutaneous surgical procedures
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-021406-38 Sponsor Protocol Number: Finaledition Start Date*: 2012-08-28
    Sponsor Name:Mariefreds Vårdcentral
    Full Title: EMLA CREAM AS PAIN RELIEF DURING PNEUMOCOCCAL VACCINATION
    Medical condition: Pain relief with Emla cream during Pneumococcal vaccination.
    Disease:
    Population Age: Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2014-001988-12 Sponsor Protocol Number: 1.2000 Start Date*: 2015-02-02
    Sponsor Name:Academic Medical Center, Amsterdam
    Full Title: Fractional CO2 laser assisted delivery of topical articaine and epinephrine solution vs. topical EMLA administration: a randomized controlled pilot study
    Medical condition: local anesthesia of the skin prior to laser therapy of acne and traumatic scars
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-004653-96 Sponsor Protocol Number: PSD502-PM-002 Start Date*: 2006-01-30
    Sponsor Name:Plethora Solutions Limited
    Full Title: Phase II, single centre, randomised, double-blind, placebo-controlled study to determine the efficacy, safety and tolerability of PSD502 in the management of pain in subjects undergoing treatment f...
    Medical condition: Acute minor burns
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2019-000700-14 Sponsor Protocol Number: 2 Start Date*: 2019-07-08
    Sponsor Name:Medical University Graz
    Full Title: Pilot-Study comparing analgosedation concepts during placement of regional anaesthesia with either fentanyl, remifentanil, clonidine, EMLA-Patch or placebo in regard of patient's wellbeing, pain an...
    Medical condition: Patient with elective orthopedic surgery that will be administered a regional anaesthesia will be subject of the investigation
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2010-018466-22 Sponsor Protocol Number: AN09/9220 Start Date*: 2010-09-22
    Sponsor Name:University of Leeds
    Full Title: ED95 doses of commonly used local anaesthetic agents for ultrasound guided brachial plexus blocks
    Medical condition: NHS patients undergoing routine surgery on hand, arm or shoulder.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2018-000613-21 Sponsor Protocol Number: Trisolfen_H_01 Start Date*: 2018-12-06
    Sponsor Name:Medical Ethics UK Ltd
    Full Title: An open, randomised, parallel group controlled, single centre safety study to assess the safety and efficacy of Tri-Solfen in providing anaesthesia prior to surgical debridement of leg ulcers and p...
    Medical condition: Local anaesthesia prior to surgical wound debridement
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029205 - Nervous system disorders 10002091 Anaesthesia PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2007-003171-39 Sponsor Protocol Number: PSD502-PE-004 Start Date*: 2007-12-07
    Sponsor Name:Plethora Solutions Ltd
    Full Title: A phase III, multi-centre, randomized, double-blind, placebo-controlled study, with open-label follow on, to evaluate the efficacy, safety and tolerability of PDS502 in subjects with Premature Ejac...
    Medical condition: Premature Ejaculation
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036596 Premature ejaculation PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: GB (Completed) HU (Completed) CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-001128-38 Sponsor Protocol Number: pVAX/rhPSA -EP 2006 Start Date*: 2008-09-30
    Sponsor Name:Uppsala University Hospital
    Full Title: DNA Vaccine Coding for the Rhesus Prostate Specific Antigen (rhPSA) and Electroporation in Patients with Relapsed Prostate Cancer. A Phase I/II Study
    Medical condition: Patients with relapse of prostate cancer.
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-024020-26 Sponsor Protocol Number: HISTEROSALPINGOGRAFIA-2010 Start Date*: 2011-10-24
    Sponsor Name:Consorci Sanitari de Terrassa
    Full Title: Evaluación de la efectividad analgésica del euthetic mixture of local anesthetic (EMLA) en la práctica de la histerosalpingografia.
    Medical condition: Efectividad analgésica en la práctica de la histerosalpingografia
    Disease: Version SOC Term Classification Code Term Level
    14.0 10022891 - Investigations 10021170 Hysterosalpingography LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-000321-12 Sponsor Protocol Number: 001/2016 Start Date*: 2018-02-08
    Sponsor Name:ÁREA DE ATENCIÓN INTEGRADA DE ALBACETE
    Full Title: Effectiveness in preventing RAdial Spasm of different vasoDIlators and topic Local Anaesthesia during transradial cardiac catheterization: The E-RADIAL trial.
    Medical condition: Radial spasm during cardiac catheterization
    Disease: Version SOC Term Classification Code Term Level
    19.1 10047065 - Vascular disorders 10003175 Arterial spasm PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 29 03:44:02 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA